Publications by authors named "Rafael Ponce"

Claim this Profile
U
Utilizing Video-Assisted Retroperitoneal Debridement for Retroperitoneal Abscess Following Penetrating Trauma.
Brian B McCluskey, Cory J Nonnemacher, Dennis W Ashley, Rafael T Ponce

Am Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Consideration for the Nonclinical Safety Assessment of Gene Therapies.
Jeffrey S Moffit, Diann L Blanset, Jessica L Lynch, Timothy K MacLachlan, Kathleen E Meyer, Rafael Ponce

Hum Gene Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical safety assessment of engineered T cell therapies.
Herve Lebrec, Curtis C Maier, Kazushige Maki, Rafael Ponce, Jacintha Shenton

Regul Toxicol Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokines in CAR T Cell-Associated Neurotoxicity.
Juliane Gust, Rafael Ponce, W Conrad Liles, Gwenn A Garden, Cameron J Turtle

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib.
Jim S Qin, Timothy G Johnstone, Alex Baturevych, Ronald J Hause, Seamus P Ragan, Rafael Ponce

J Immunother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman Primates.
Agne Taraseviciute, Victor Tkachev, Rafael Ponce, Cameron J Turtle, Jessica M Snyder

Cancer Discov· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Delivery of OncoVEX Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade.
Achim K Moesta, Keegan Cooke, Julia Piasecki, Petia Mitchell, James B Rottman, Rafael Ponce

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma.
Tasha Hughes, Robert S Coffin, Caroline E Lilley, Rafael Ponce, Howard L Kaufman

Oncolytic Virother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New arrivals to New York City: vulnerability to HIV among urban migrant young gay men.
Paul Kobrak, Rafael Ponce, Robert Zielony

Arch Sex Behav· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.
Hervé Lebrec, Rafael Ponce, Bradley D Preston, Jan Iles, Teresa L Born

Curr Med Res Opin· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation and lymphoma in humans.
Rafael A Ponce, Thomas Gelzleichter, Helen G Haggerty, Shawn Heidel, Matthew S Holdren

J Immunotoxicol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models.
Cecile M Krejsa, Rick D Holly, Mark Heipel, Ken M Bannink, Rebecca Johnson, Rafael Ponce

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical safety, pharmacokinetics, and pharmacodynamics of recombinant human interleukin-21 in cynomolgus macaques (Macaca fascicularis).
Kimberly S Waggie, Matthew S Holdren, Kelly Byrnes-Blake, Susan Pedersen, Rafael Ponce

Int J Toxicol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in regulatory T-cells: rediscovered pathways in immunotoxicology.
Emanuela Corsini, Mohamed Oukka, Raymond Pieters, Nancy I Kerkvliet, Rafael Ponce

J Immunotoxicol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety assessment of immunomodulatory biologics: the promise and challenges of regulatory T-cell modulation.
Rafael A Ponce

J Immunotoxicol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICH S9: Developing anticancer drugs, one year later.
Rafael Ponce

Toxicol Pathol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquitinated proteins, and apoptosis in mouse embryonic fibroblast cells.
Xiaozhong Yu, Jaspreet S Sidhu, Sungwoo Hong, Joshua F Robinson, Rafael A Ponce

Toxicol Sci· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.
John L Vahle, Gregory L Finch, Shawn M Heidel, David N Hovland, Inge Ivens, Rafael A Ponce

Toxicol Pathol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies.
Rafael Ponce, Leslie Abad, Lakshmi Amaravadi, Thomas Gelzleichter, Elizabeth Gore

Regul Toxicol Pharmacol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hair methylmercury levels of mummies of the Aleutian Islands, Alaska.
G M Egeland, Rafael Ponce, Nicolas S Bloom, Rick Knecht, Stephen Loring

Environ Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical support for combination therapy in the treatment of autoimmunity with atacicept.
Rafael Ponce

Toxicol Pathol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept.
Michela Carbonatto, Ping Yu, Mauro Bertolino, Enrico Vigna, Stephanie Steidler, Rafael Ponce

Toxicol Sci· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?
Janet Clarke, Christopher Hurst, Pauline Martin, John Vahle, Rafael Ponce

Regul Toxicol Pharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse consequences of immunostimulation.
Rafael Ponce

J Immunotoxicol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity as a result of immunostimulation by biologics.
Elizabeth J Gribble, Pallavar V Sivakumar, Rafael A Ponce, Steven D Hughes

Expert Opin Drug Metab Toxicol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis